ML1707
Alzheimer's Disease, Frontotemporal Dementia
PreclinicalActive
Key Facts
About Medilabo
Medilabo develops intranasal drug delivery technology to treat neurodegenerative diseases by directly targeting the brain via the olfactory nerve.
View full company profile